Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sarcodoxome
- Development stage
- Preclinical
- Lead developer
- GP Pharm
- Modality
- Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Intravenous
01
Overview
Sarcodoxome is a liposomal formulation of the cytotoxic anthracycline doxorubicin, developed by the Spanish pharmaceutical company GP Pharm (part of the Lipotec Group). The drug utilizes a liposomal delivery system to encapsulate doxorubicin, which is intended to improve the therapeutic index by enhancing drug accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect while minimizing distribution to healthy tissues, thereby reducing common side effects such as cardiotoxicity and alopecia. Doxorubicin exerts its antineoplastic effect by intercalating between DNA base pairs and inhibiting the enzyme topoisomerase II, which triggers DNA strand breakage and subsequent apoptosis. Sarcodoxome is primarily targeted for use in oncology for the treatment of various solid tumors and hematological malignancies.
- Brand names
- Sarcodoxome
- Other names
- Liposomal doxorubicin
02
Targets
TOP2A (DNA topoisomerase II)DNA
Beyond the preview
Go deeper on Sarcodoxome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sarcodoxome.